Detalhe da pesquisa
1.
Efficacy and Safety of a Tetravalent Dengue Vaccine (TAK-003) in Children With Prior Japanese Encephalitis or Yellow Fever Vaccination.
J Infect Dis
; 2024 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38682569
2.
Long-term Safety and Immunogenicity of a Tetravalent Dengue Vaccine Candidate in Children and Adults: A Randomized, Placebo-Controlled, Phase 2 Study.
J Infect Dis
; 225(9): 1513-1520, 2022 05 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32658250
3.
Efficacy of a Dengue Vaccine Candidate (TAK-003) in Healthy Children and Adolescents 2 Years after Vaccination.
J Infect Dis
; 225(9): 1521-1532, 2022 05 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33319249
4.
Three-year Efficacy and Safety of Takeda's Dengue Vaccine Candidate (TAK-003).
Clin Infect Dis
; 75(1): 107-117, 2022 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34606595
5.
Efficacy of a Tetravalent Dengue Vaccine in Healthy Children and Adolescents.
N Engl J Med
; 381(21): 2009-2019, 2019 11 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-31693803
6.
Safety and immunogenicity of a tetravalent dengue vaccine in children aged 2-17 years: a randomised, placebo-controlled, phase 2 trial.
Lancet
; 395(10234): 1434-1443, 2020 05 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32197107
7.
Efficacy of a tetravalent dengue vaccine in healthy children aged 4-16 years: a randomised, placebo-controlled, phase 3 trial.
Lancet
; 395(10234): 1423-1433, 2020 05 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32197105
8.
Immunogenicity and safety of a tetravalent dengue vaccine in dengue-naïve adolescents in Mexico City.
Rev Panam Salud Publica
; 45: e67, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34131423
9.
Development of standard clinical endpoints for use in dengue interventional trials: introduction and methodology.
BMC Med Res Methodol
; 18(1): 134, 2018 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30442099
10.
Safety and Immunogenicity of a Tetravalent Dengue Vaccine Candidate in Healthy Children and Adults in Dengue-Endemic Regions: A Randomized, Placebo-Controlled Phase 2 Study.
J Infect Dis
; 213(10): 1562-72, 2016 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26704612
11.
Long-term efficacy and safety of a tetravalent dengue vaccine (TAK-003): 4·5-year results from a phase 3, randomised, double-blind, placebo-controlled trial.
Lancet Glob Health
; 12(2): e257-e270, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38245116
12.
Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial.
Lancet
; 380(9853): 1559-67, 2012 Nov 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-22975340
13.
A randomized phase 3 trial of the immunogenicity and safety of coadministration of a live-attenuated tetravalent dengue vaccine (TAK-003) and an inactivated hepatitis a (HAV) virus vaccine in a dengue non-endemic country.
Vaccine
; 41(7): 1398-1407, 2023 02 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36681529
14.
Effect of the Tetravalent Dengue Vaccine TAK-003 on Sequential Episodes of Symptomatic Dengue.
Am J Trop Med Hyg
; 108(4): 722-726, 2023 04 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36878213
15.
Immunogenicity and safety of concomitant and sequential administration of yellow fever YF-17D vaccine and tetravalent dengue vaccine candidate TAK-003: A phase 3 randomized, controlled study.
PLoS Negl Trop Dis
; 17(3): e0011124, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36888687
16.
Consistency of immunogenicity in three consecutive lots of a tetravalent dengue vaccine candidate (TAK-003): A randomized placebo-controlled trial in US adults.
Vaccine
; 41(47): 6999-7006, 2023 11 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37884415
17.
p75 neurotrophin receptor regulates tissue fibrosis through inhibition of plasminogen activation via a PDE4/cAMP/PKA pathway.
J Cell Biol
; 177(6): 1119-32, 2007 Jun 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-17576803
18.
Phosphorylation of cAMP-specific PDE4A5 (phosphodiesterase-4A5) by MK2 (MAPKAPK2) attenuates its activation through protein kinase A phosphorylation.
Biochem J
; 435(3): 755-69, 2011 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21323643
19.
Characterization of the cell-mediated immune response to Takeda's live-attenuated tetravalent dengue vaccine in adolescents participating in a phase 2 randomized controlled trial conducted in a dengue-endemic setting.
Vaccine
; 40(8): 1143-1151, 2022 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35078666
20.
A simplified and affordable approach to forest monitoring using single terrestrial laser scans and transect sampling.
MethodsX
; 8: 101484, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34434882